Browse diseases

…or other common indications such as heart failure, diabetes, or chronic kidney disease.33 Furthermore, a reduction in the proportion of those taking c…

…rs targeting CD70 show early promising results for their use in RCC in preclinical and clinical trials. However, further research a…

…mptoms become more severe over a short period of time. Although asthma attacks can often be self-treated by individuals with prescribe…

…esigned studies. To focus on the metastatic setting relevant to oligometastatic disease, trials referring to early-stage (stage I–II) or locally advanc…

…kin-6; LN, laminin; LDL-C, low-density lipoprotein cholesterol; MASLD, metabolic dysfunction-associated steatotic liver disease; PC I…

…cy over metformin in mitigating dementia risk, particularly for AD (AHR 0.88) and non-VaDs (AHR 0.75), likely through distinct neu…

…the ordinal psychological burdens, without any adjustment (M1), type 2 diabetes was associated with higher odds of reporting being “neither sat…

…vascular outcome or the most similar alternative. The composite chronic kidney disease outcome comprised end stage kidney disease, estimated glomerula…

… When predicting risks in a general population of patients with chronic kidney disease, for example when identifying patients for referral to renal cl…

…ed on a nested case-control cohort with DNAm data was selected. T1D cases were matched 1:1 with controls based on age, sex, T1D fam…

…CKD ( table 1).Table 1Baseline characteristics of patients with T2DM and hypertension stratified by FIB-4 indexTotal (n=1208)FIB-4 ≤…

…atohepatitisAlteration of demographic & metabolic parameters in steatohepatitis subjects with or without T2DParameters (normal value)T2D (N=40)…